5-amino levulinic acid inhibits SARS-CoV-2 infection in vitro
Y. Sakurai, M. M. N. Tun, Y. Kurosaki, T. Sakura, D. K. Inaoka, K. Fujine, K. Kita, K. Morita, J. Yasuda
This study shows that 5-ALA inhibits SARS-CoV-2 infection in vitro in both human and non-human cells with low cytotoxicity, suggesting it as a potential oral antiviral drug for COVID-19.
bioRxiv · Oct 28, 2020Microbiology